Medical validation: April 11, 2016Dr Jesus CardenasAllergologist
Discovered in 1817 by a British doctor who gave it his name, Parkinson's disease affects 200,000 people in France. The diagnosis generally falls nearly 10 years after the onset of the disease. Too often still the sluggishness and tremors are attributed to the simple effect of aging.
Discovered in 1817, Parkinson's disease is still far from revealing all its secrets. Affecting the nervous system, its cause is still not known. The disease is characterized by the disappearance of a small number of nerve cells (neurons) which secrete a neurotransmitter called dopamine involved in the proper functioning of many regions of the brain, and essential for cell survival.
Dopamine is a neurotransmitter (chemical substance released by neurons that transmit impulses) at the junctions between nerve cells (synapses).
Synapses are areas where neurons exchange information. At this level, information is exchanged in the form of chemical messages. Chemicals called neurotransmitters are secreted and bind to specific receptors.
1: Nerve impulse 2: Neurotransmitter (dopamine) 3: Dopamine-specific receptor 4: Dopamine reuptake system
Each year, 25,000 new cases are diagnosed in France. Although this disease is generally diagnosed between the ages of 55 and 65 (average age of diagnosis: 58), 5 to 10% of patients are affected at much younger ages (between 30 and 55).
The appearance of the first symptoms is gradual. After a period of intense fatigue, Parkinson's disease is manifested by:
Check my blog post on how to create a Control Chart in Painting! A useful tool to monitor a process variable over ti… https://t.co/bDcfh3e08p
— Jose Valero Tue Jun 25 20:41:08 +0000 2019
These motor control disorders are most often associated with specific psychological aspects due to dopamine deficiency. These symptoms (depression, excessive anxiety) are often ignored by the general public.
Age remains the main risk factor. However, various avenues have also been explored1 , including:
Apart from exposure to pesticides, where studies have been conducted by Inserm researchers, no study has succeeded in demonstrating the slightest relationship between Parkinson's disease and other risk factors.
Certain aggravating factors have however been brought to light, including taking neuroleptics or certain psychological situations (depression, etc.).
Only the protective role of smoking seems to be proven by epidemiological surveys. The latest 2 involves twins and again shows that the risk of Parkinson's disease is inversely correlated with cigarette smoking. This effect would be linked to the action of nicotine which stimulates the release of dopamine and compensates for the dopaminergic deficits which characterize the disease.
Even if exceptional cases have been identified of families affected several times by the disease, no study confirms the existence of a systematic hereditary transmission. There is a genetic susceptibility, but it remains quite low. 21 genetic variants associated with the disease have been identified to date. But none of these variants is individually strong enough to cause disease. It is estimated today that there are about 5% of genetic forms linked to mutations affecting specific genes.
The diagnosis is not easy, the signs are progressive and too often imprecise: rheumatic pain, depression, intense fatigue... the entourage and the patient themselves find it difficult to isolate the symptoms. Alerted, the general practitioner, psychologist or rheumatologist directs the patient to a neurologist to confirm the presence of the disease. Thanks to various tests, the specialist will be able to identify Parkinson's disease by exclusion. The diagnosis can take a few weeks to a few months to confirm the installation of discreet disorders at the beginning, then more and more clear.
See alsoArticleDiagnostic criteria used by the French National Authority for Health3 are the four essential signs of the disease:
Other causes that may be at the origin of the same manifestations must also be excluded. Finally, a positive response to dopaminergic drugs (L-Dopa) is a diagnostic criterion.
Parkinson's disease has several stages of development, indicating the severity of the disorder:
Despite the latest medical advances, there is currently no cure for Parkinson's disease. Thus, the aim of the treatment is to correct the symptoms, in particular the motor ones, and to attenuate their consequences on the daily and social life of the patient.
The purpose of the medications used is to provide the brain with the dopamine it lacks or to slow down cholinergic activity. For nearly thirty years, L-Dopa has been the most effective treatment for this disease. It minimizes the consequences of neuronal losses by restoring the deficit of dopamine synthesis. We speak today of "dopatherapy".
However, if its action is indisputable in the short term, it could aggravate motor symptoms after a few years. Other substances, known as "dopaminergic agonists" can then take over. But these drugs (bromocriptine, lisuride, piribedil, ropinirole, apomorphine, pergolide, entacapone) are less effective. They are currently reserved for the youngest patients to avoid exposing them too early to the side effects of L-Dopa.
Neurosurgery also offers an alternative for some patients (5% of patients). Through a surgical procedure, a specific region of the brain is stimulated with electrodes. These electrodes are connected by a subcutaneous cable to a small stimulation box placed just under the collarbone. Stimulation brings considerable relief and, in the vast majority of cases, a real transformation in the lives of patients. This technique is very effective on tremors, stiffness and difficulty in performing movements. One downside, however: deep brain stimulation can only be offered to people who have been sick for more than 5 years, and who do not have psychiatric disorders. If the patient's age is not a major selection criterion, his state of health must be satisfactory.
Physiotherapy to maintain muscles and joints and speech therapy to improve swallowing, speaking and writing are treatment options that should not be overlooked.
A study conducted by the France Parkinson association, more than 2 out of 3 patients (77.2%) have to limit their outdoor activities because of their symptoms.
Family life is also weakened by the disease: 22.7% of patients say that the relationship with their spouse is affected and 22.7% note that their friends are estranged. Worse still, 37% of people with Parkinson's disease feel like they are a burden to those around them.
Concerning the external vision of this disease, much remains to be done. The symptoms of Parkinson's are still largely misunderstood: they are perceived as drunkenness or a drugged state in 77.9% of cases, simulation (74.1%) or madness (64.5%).
There are many research challenges:
Codeco of December 3, 2021: the new measures target schools, masks, events, but not the horeca
GO
Sunburn: how to make up for the damage? - Miss
GO
How to Get Free N95 Masks from the US Government
GO
Beauty coaching: can I apply oil if I have oily skin?
GO